Mesa Laboratories (MLAB) Long-Term Deferred Tax (2018 - 2025)

Mesa Laboratories has disclosed Long-Term Deferred Tax across 8 years of filings, most recently posting $1.5 million for Q4 2025.

• Long-Term Deferred Tax for Q4 2025 came in at $1.5 million, up 7.51% year-over-year; the trailing twelve-month figure through Dec 2025 was $1.5 million (up 7.51% YoY), and the FY2025 annual result was $1.4 million, up 6.11% from the prior year.
• Long-Term Deferred Tax came in at $1.5 million for Q4 2025 at Mesa Laboratories, roughly flat from $1.5 million in the prior quarter.
• In the past five years, Long-Term Deferred Tax ranged from a high of $1.9 million in Q3 2021 to a low of $594000.0 in Q4 2021.
• The 5-year median for Long-Term Deferred Tax is $1.2 million (2023), against an average of $1.1 million.
• Across the five-year window, Long-Term Deferred Tax plunged 96.21% in 2021 and soared 113.96% in 2022, its largest moves.
• Mesa Laboratories' Long-Term Deferred Tax stood at $594000.0 in 2021, then grew by 19.19% to $708000.0 in 2022, then jumped by 54.24% to $1.1 million in 2023, then climbed by 25.55% to $1.4 million in 2024, then increased by 7.51% to $1.5 million in 2025.
• The last three Long-Term Deferred Tax figures came in at $1.5 million (Q4 2025), $1.5 million (Q3 2025), and $1.5 million (Q2 2025), per Business Quant data.